+ Filter
Loading...
Custom Services order now ship next day

CDK4

Anti-CDK4 Recombinant Antibody Products

More Infomation

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs specializes in premium anti-CDK4 antibodies, providing an extensive selection of rigorously tested products designed for superior performance. Our dedicated team provides expert customer support, ensuring your research goals are achieved with great efficacy and accuracy. Whether you're investigating cell cycle regulation, cancer biology, or drug discovery, our anti-CDK4 antibodies offer precision and reliability.

CDK4: A Promising Target for Cancer Therapies

Cyclin-dependent kinase 4 (CDK4) is an essential cell cycle regulator, especially during the S phase transition. Its deregulation is commonly observed in various human tumors, such as breast cancer, gliomas, and melanomas, often through mechanisms like amplification or overexpression. Moreover, CDK4 has been identified as a prognostic marker, particularly in triple-negative breast cancer (TNBC). Owing to its noteworthy role in the advancement of cancer, CDK4 represents a very intriguing avenue for investigational cancer treatments.

Alternative Names

Cyclin-dependent kinase 4; CMM3; cyclin dependent kinase 4; cell division protein kinase 4; PSK-J3; EC 2.7.11.22; EC 2.7.11.

Background

The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported.

Protein class

Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins

Predicted location

Intracellular

Single cell type specificity

Low cell type specificity

Immune cell specificity

Low immune cell specificity

Cell line specificity

Group enriched (HBEC3-KT, LHCN-M2, RH-30)

Interaction

Component of the D-CDK4 complex, composed of CDK4 and some D-type G1 cyclin (CCND1, CCND2 or CCND3). Interacts directly in the complex with CCND1, CCND2 or CCND3. Interacts with SEI1 and ZNF655. Forms a ternary complex, cyclin D-CDK4-CDKN1B, involved in modulating CDK4 enzymatic activity. Interacts directly with CDKN1B (phosphorylated on 'Tyr-88' and 'Tyr-89'); the interaction allows assembly of the cyclin D-CDK4 complex, Thr-172 phosphorylation, nuclear translocation and enhances the cyclin D-CDK4 complex activity. CDK4 activity is either inhibited or enhanced depending on stoichiometry of complex. The non-tyrosine-phosphorylated form of CDKN1B prevents T-loop phosphorylation of CDK4 producing inactive CDK4. Interacts (unphosphorylated form) with CDK2. Also forms ternary complexes with CDKN1A or CDKN2A. Interacts directly with CDKN1A (via its N-terminal); the interaction promotes the assembly of the cyclin D-CDK4 complex, its nuclear translocation and promotes the cyclin D-dependent enzyme activity of CDK4. Interacts with CCND1; the interaction is prevented with the binding of CCND1 to INSM1 during cell cycle progression. Probably forms a complex composed of chaperones HSP90 and HSP70, co-chaperones CDC37, PPP5C, TSC1 and client protein TSC2, CDK4, AKT, RAF1 and NR3C1; this complex does not contain co-chaperones STIP1/HOP and PTGES3/p23 (PubMed:29127155). Interacts with CEBPA (when phosphorylated) (PubMed:15107404). Interacts with FNIP1 and FNIP2 (PubMed:27353360).

Molecular function

Kinase, Serine/threonine-protein kinase, Transferase

More Types Infomation

Anti-CDK4 rAb Products

Creative Biolabs offers a comprehensive range of anti-CDK4 antibodies designed to specifically block CDK4 protein. We offer our products in multiple formats to accommodate a wide array of experimental methods, ensuring seamless integration into your research workflows. In addition, we are committed to providing high-quality antibodies at competitive prices to meet the specific needs of researchers.

Table 1. Featured anti-CDK4 recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
VS3-FY348 Recombinant Rabbit Anti-CDK4 Antibody (clone R07-4G7) Human Rabbit IgG WB, IHC, IF
VS-0423-CJ3 Human Anti-CDK4 Recombinant Antibody (clone AK2) Human Human IgG ELISA, IF
VS3-FY346 Recombinant Rabbit Anti-CDK4 Antibody (clone R04-4I5) Human, Mouse, Rat Rabbit IgG WB, IHC-F, IHC-P, IHC, IF, IP
ZG-0613J Rabbit Anti-CDK4 Recombinant Antibody (clone 8H4) Human Rabbit IgG ELISA, WB
ZG-0404F Mouse Anti-Cdk4 Recombinant Antibody (ZG-0404F) Human, Mouse, Rat, Dog, Pig Mouse IgG WB

Creative Quality Control

Creative Biolabs is committed to empowering researchers with a diverse selection of high-quality anti-CDK4 antibodies. Each antibody undergoes stringent quality assurance processes to ensure exceptional performance in a variety of applications. Our dedication to excellence ensures that our products adhere to the highest standards in the industry, providing researchers with dependable and consistent results.

Fig.1 WB analysis. (Creative Biolabs Original)Fig.1 WB analysis of anti-CDK4 antibody
(Cat# VS3-FY346, Creative Biolabs).

Fig.2 IHC analysis. (Creative Biolabs Original)Fig.2 IHC analysis of anti-CDK4 antibody
(Cat# VS3-FY346, Creative Biolabs)

Fig.3 WB analysis. (Creative Biolabs Original)Fig.3 WB analysis of anti-CDK4 antibody
(Cat# ZG-0613J, Creative Biolabs).

Fig.4 IP analysis. (Creative Biolabs Original)Fig.4 IP analysis of anti-CDK4 antibody
(Cat# ZG-0612J, Creative Biolabs)

Customer Reviews

Excellent
Ku***u
Rabbit Anti-CDK4 Recombinant Antibody (clone CBACN-139) (MRO-0341-CN)
Creative Biolabs' anti-CDK4 antibody consistently demonstrated exceptional specificity and sensitivity in my Western blotting experiments. The antibody reliably detected CDK4 protein bands with minimal background interference, even at low protein concentrations. This high-quality performance has been invaluable in accurately quantifying CDK4 expression levels in various cell lines.
22/Oct/2021
Excellent
Al***n
Mouse Anti-CDK4 Recombinant Antibody (clone DCS31.2) (ZG-0794F)
I am highly satisfied with the performance of Creative Biolabs' anti-CDK4 antibody in immunoprecipitation experiments. The antibody efficiently pulled down CDK4 protein from cell lysates, resulting in clean immunoprecipitates with minimal non-specific binding. This enabled me to effectively analyze the interactions between CDK4 and its associated proteins.
17/Aug/2022
Excellent
Ch***s
Recombinant Rabbit Anti-CDK4 Antibody (clone R07-4G7) (VS3-FY348)
Creative Biolabs' anti-CDK4 antibody was a standout performer in my immunofluorescence studies. The antibody consistently yielded sharp, clear staining of CDK4 protein, allowing me to precisely visualize its subcellular distribution.
13/Nov/2023

rAb Production

Our advanced recombinant antibody platform leverages genetic engineering to produce high-performance anti-CDK4 antibodies. This cutting-edge system enables efficient and scalable manufacturing, ensuring a reliable supply for diverse applications.

Featured Anti-CDK4 Recombinant Antibody Production PlatformsFig.5 Milligram-scale. (Creative Biolabs Original)
Fig.5 Milligram-scale anti-CDK4 recombinant antibody production.

Fig.6 Gram-scale. (Creative Biolabs Original)Fig.6 Gram-scale anti-CDK4 recombinant antibody production.

rAb Modalities

Creative Biolabs offers a wide range of high-quality anti-CDK4 recombinant antibodies in various formats to suit your specific research needs.

Fig.7 CDK4 antibody production and modalities. (Creative Biolabs Original)Fig.7 Full-length anti-CDK4 recombinant antibody production and modalities.

CDK4-Targeted Drug Information

Table 2. Public drug targeting CDK4.

Highest Phase Mechanism of Action Product Category Condition Organization
Launched - 2017 Aromatase (CYP19A1) Inhibitors
Cyclin-Dependent Kinase 4 (CDK4) Inhibitors
Cyclin-Dependent Kinase 6 (CDK6) Inhibitors
Signal Transduction Modulators
Cancer Hormone Therapy
Multi-Component Products
Radiosensitizers
Cancer, breast Novartis (Originator)
Phase I/II Cyclin-Dependent Kinase 4 (CDK4) Inhibitors
Signal Transduction Modulators
Peptides Cancer, bladder
Cancer, colorectal
Digestive-gastrointestinal cancer
Glioblastoma multiforme
Melanoma
MetaMax (Originator)
IND Filed Cyclin-Dependent Kinase 4 (CDK4) Degradation Inducers
Cyclin-Dependent Kinase 6 (CDK6) Degradation Inducers
Drugs Targeting Protein Cereblon (CRBN)
Signal Transduction Modulators
PROTACs (Proteolysis Targeting Chimeras) Cancer, breast
Cancer, solid tumor
BioTheryX (Originator)
Preclinical Cyclin-Dependent Kinase 4 (CDK4) Degradation Inducers
Cyclin-Dependent Kinase 6 (CDK6) Degradation Inducers
Drugs Targeting Von Hippel-Lindau Disease Tumor Suppressor (VHL)
Signal Transduction Modulators
Oligopeptides, less than 10 AA
PROTACs (Proteolysis Targeting Chimeras)
Cancer Icahn School of Medicine at Mount Sinai (Originator)
Biological Testing CDK4/Cyclin D3 Inhibitors
CDK6/Cyclin D3 Inhibitors
Cyclin-Dependent Kinase 4 (CDK4) Inhibitors
Cyclin-Dependent Kinase 6 (CDK6) Inhibitors
Drugs Targeting EGFR (HER1; erbB1)
Signal Transduction Modulators
Antibody-Drug Conjugates (ADCs)
Cancer Immunotherapy
Chimeric Monoclonal Antibodies
Cancer Yonsei University (Originator)
Biological Testing Cyclin-Dependent Kinase 4 (CDK4) Degradation Inducers
Cyclin-Dependent Kinase 6 (CDK6) Degradation Inducers
Drugs Targeting Inhibitor of Apoptosis Proteins (IAP)
Signal Transduction Modulators
Oligopeptides, less than 10 AA
PROTACs (Proteolysis Targeting Chimeras)
SNIPERs (Specific and Nongenetic IAP-Dependent Protein Eraser)
Cancer GSK (Originator)
Biological Testing Cyclin-Dependent Kinase 4 (CDK4) Degradation Inducers
Cyclin-Dependent Kinase 6 (CDK6) Degradation Inducers
Drugs Targeting Von Hippel-Lindau Disease Tumor Suppressor (VHL)
Signal Transduction Modulators
Oligopeptides, less than 10 AA
PROTACs (Proteolysis Targeting Chimeras)
Cancer GSK (Originator)
Biological Testing Cyclin-Dependent Kinase 4 (CDK4) Inhibitors
Cyclin-Dependent Kinase 6 (CDK6) Inhibitors
Signal Transduction Modulators
Polypeptides, from 10 AA to 40 AA Cancer Cyclacel (Originator)

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

As a pioneer in antibody research, Creative Biolabs combines a strong theoretical foundation with extensive practical experience to deliver affordable, high-quality anti-CDK4 antibodies. If you want to learn more about our anti-CDK4 antibody, please feel free to contact us.

  • 0
  • 0
Cart
    Go to compare

    Go to compare